NCT01536522View on ClinicalTrials.gov

Asthma Inflammation Research

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
AsthmaAllergic AsthmaNon-allergic Asthma
Interventions
DIETARY_SUPPLEMENT

Nutritional approach for asthma

participants will be provided a medium chain triglyceride supplement or placebo

DIETARY_SUPPLEMENT

Low Caloric Shake

participants will be provided a low caloric dietary shake

BIOLOGICAL

whole lung allergen challenge

inhalation of allergens by allergic patients with or without asthma, will be used to define mechanisms underlying the development of airway inflammation

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER